LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis

Cisplatin resistance is a major therapeutic challenge in non-small cell lung cancer (NSCLC). Herein, the regulatory role of long non-coding RNA (lncRNA) ITGB2-AS1 in regulating NSCLC cisplatin resistance was investigated. NSCLC cisplatin resistance cells were constructed using A549 and H1975 cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huiyong, Wang, Linhui, Liu, Jingting, Wan, Zihao, Zhou, Lin, Liao, Hongliang, Wan, Renping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308868/
https://www.ncbi.nlm.nih.gov/pubmed/37370246
http://dx.doi.org/10.1080/15384047.2023.2223377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308868/
https://www.ncbi.nlm.nih.gov/pubmed/37370246
http://dx.doi.org/10.1080/15384047.2023.2223377

Ejemplares similares